Research ArticleArticles
Treatment of Psoriatic Arthritis with Tumor Necrosis Factor Inhibitors: Longer-term Outcomes Including Enthesitis and Dactylitis with Golimumab Treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL)
ARTHUR KAVANAUGH and PHILIP MEASE
The Journal of Rheumatology Supplement July 2012, 89 90-93; DOI: https://doi.org/10.3899/jrheum.120254
REFERENCES
- 1.↵
- Ceponis A,
- Kavanaugh A
- 2.↵
- Mease PJ
- 3.↵
- Kavanaugh A,
- McInnes I,
- Mease P,
- Krueger GG,
- Gladman D,
- Gomez-Reino J,
- et al.
- 4.↵
- Heuft-Dorenbosch L,
- Spoorenberg A,
- van Tubergen A
- 5.↵
- 6.↵
- Prevoo ML,
- van ’t Hof MA,
- Kuper HH,
- van Leeuwen MA,
- van de Putte LB,
- van Riel PL
- 7.↵
- Wells G,
- Becker JC,
- Teng J,
- Dougados M,
- Schiff M,
- Smolen J,
- et al.
- 8.↵
- Kavanaugh AF,
- Ritchlin CT;
- GRAPPA Treatment Guideline Committee
- 9.↵
- Ritchlin C,
- Kavanaugh A,
- Gladman DD,
- Mease PJ,
- Helliwell P,
- Boehncke WH,
- et al.
- 10.↵
- Gossec L,
- Smolen JS,
- Gaujoux-Viala C,
- Ash Z,
- Marzo-Ortega H,
- van der Heijde D,
- et al.
- 11.↵
- Coates LC,
- Fransen J,
- Helliwell PS
- 12.↵
- 13.↵
- Coates LC,
- McGonagle DM,
- Hodgson R,
- Kavanaugh AF,
- Qureshi AA,
- Fitzerald O,
- et al.
In this issue
Treatment of Psoriatic Arthritis with Tumor Necrosis Factor Inhibitors: Longer-term Outcomes Including Enthesitis and Dactylitis with Golimumab Treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL)
ARTHUR KAVANAUGH, PHILIP MEASE
The Journal of Rheumatology Supplement Jul 2012, 89 90-93; DOI: 10.3899/jrheum.120254
Treatment of Psoriatic Arthritis with Tumor Necrosis Factor Inhibitors: Longer-term Outcomes Including Enthesitis and Dactylitis with Golimumab Treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL)
ARTHUR KAVANAUGH, PHILIP MEASE
The Journal of Rheumatology Supplement Jul 2012, 89 90-93; DOI: 10.3899/jrheum.120254